These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3323895)

  • 1. [Intensified conventional insulin therapy in children and adolescents with type I diabetes].
    Wolf J; Wolf E; Hürter P
    Monatsschr Kinderheilkd; 1987 Nov; 135(11):770-4. PubMed ID: 3323895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy.
    Carta Q; Meriggi E; Trossarelli GF; Catella G; Dal Molin V; Menato G; Gagliardi L; Massobrio M; Vitelli A
    Diabete Metab; 1986 Jun; 12(3):121-9. PubMed ID: 3525266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.
    Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z
    Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    J Pediatr Endocrinol Metab; 2002 May; 15(5):607-12. PubMed ID: 12014519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified insulin therapy in the type I diabetic adolescent: a controlled trial.
    Schiffrin AD; Desrosiers M; Aleyassine H; Belmonte MM
    Diabetes Care; 1984; 7(2):107-13. PubMed ID: 6376006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
    Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
    Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring.
    Arias P; Kerner W; Zier H; Navascués I; Pfeiffer EF
    Diabetes Care; 1985; 8(2):134-40. PubMed ID: 3888562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta-Analysis and Prospective Cohort Study.
    Wang X; Zhao X; Chen D; Zhang M; Gu W
    Front Endocrinol (Lausanne); 2021; 12():608232. PubMed ID: 33737909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI.
    Johannesen J; Eising S; Kohlwes S; Riis S; Beck M; Carstensen B; Bendtson I; Nerup J
    Pediatr Diabetes; 2008 Feb; 9(1):23-8. PubMed ID: 18211633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
    Shashaj B; Sulli N
    Diabetes Technol Ther; 2009 Dec; 11(12):767-74. PubMed ID: 20001677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].
    Pańkowska E; Lipka M; Wysocka M; Szypowska A; Trippenbach-Dulska H; Czaplińska M; Kołodziejska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):11-5. PubMed ID: 12831632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.